Yutaka Kakizoe

Author PubWeight™ 6.69^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension.	J Hypertens	2009	0.95
2	In vivo contribution of serine proteases to the proteolytic activation of γENaC in aldosterone-infused rats.	Am J Physiol Renal Physiol	2012	0.94
3	The antifibrotic effect of a serine protease inhibitor in the kidney.	Am J Physiol Renal Physiol	2013	0.85
4	Increased susceptibility of db/db mice to rosiglitazone-induced plasma volume expansion: role of dysregulation of renal water transporters.	Am J Physiol Renal Physiol	2013	0.82
5	Renin angiotensin antagonists normalize aberrant activation of epithelial sodium channels in sodium-sensitive hypertension.	Nephron Exp Nephrol	2013	0.81
6	Effect of a serine protease inhibitor on the progression of chronic renal failure.	Am J Physiol Renal Physiol	2012	0.79
7	Regulation of adrenal aldosterone production by serine protease prostasin.	J Biomed Biotechnol	2010	0.79
8	mPGES-1-derived PGE2 mediates dehydration natriuresis.	Am J Physiol Renal Physiol	2012	0.78
9	The serine protease inhibitor camostat mesilate attenuates the progression of chronic kidney disease through its antioxidant effects.	Nephron	2015	0.75